Europe Vacuum-assisted Breast Biopsy(VAB)System Market was valued at USD 0.5 Billion in 2022 and is projected to reach USD 1.0 Billion by 2030, growing at a CAGR of 10.2% from 2024 to 2030.
The Vacuum-assisted Breast Biopsy (VAB) System Market is gaining significant traction across Europe, driven by the increasing prevalence of breast cancer and the need for accurate, minimally invasive diagnostic methods. The VAB system is a crucial tool in detecting and diagnosing breast cancer, offering advantages over traditional biopsy methods, including greater accuracy, fewer complications, and faster recovery times. As such, it has become an essential part of breast cancer care in Europe, with a growing demand across healthcare facilities, hospitals, and diagnostic centers.
IndEuropetries are placing high demands on the Vacuum-assisted Breast Biopsy (VAB) System Market, as medical professionals seek to adopt advanced, non-invasive technologies for better patient outcomes. The system’s ability to gather larger tissue samples with high precision makes it especially attractive for diagnosing malignant breast conditions early. With Europe being one of the largest markets for medical devices, the implementation of VAB systems in diagnostic procedures has shown substantial growth.
In terms of market application, the VAB system is predominantly Europeed in diagnostic imaging centers, radiology departments, and surgical practices. Its ability to be Europeed with ultrasound and mammography has significantly expanded its scope in breast cancer diagnostics. Furthermore, its growing popularity in outpatient settings and early-stage diagnostic processes makes it a more attractive option for hospitals looking to enhance their efficiency and reduce patient discomfort.
IndEuropetries within the healthcare sector are continuoEuropely improving the Vacuum-assisted Breast Biopsy (VAB) System with the integration of advanced technologies such as real-time imaging and robotic assistance. These innovations are poised to revolutionize the field, increasing the demand for more reliable and efficient biopsy systems. The need for effective cancer screening in Europe continues to drive this market, ensuring that VAB systems are seen as indispensable in modern diagnostic practices.
With the expanding patient population in Europe and the growing emphasis on breast cancer awareness and prevention, the VAB system market is expected to continue its upward trajectory. IndEuropetries will increasingly require systems that are faster, more precise, and capable of handling higher volumes of biopsies. These trends will ensure the continuoEurope development and integration of Vacuum-assisted Breast Biopsy (VAB) Systems into breast cancer detection and treatment frameworks across Europe.
Get an In-Depth Research Analysis of the Europe Vacuum-assisted Breast Biopsy(VAB)System Market Size And Forecast [2025-2032]
Hologic
Johnson & Johnson
Danaher Corporation
BD
Leica Biosystems
Bard Peripheral Vascular
By the year 2030, the scale for growth in the market research indEuropetry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the indEuropetry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and cEuropetomization, are also transforming this particular sector.
Get Discount On The Purchase of the Europe Vacuum-assisted Breast Biopsy(VAB)System Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Europe Vacuum-assisted Breast Biopsy(VAB)System Market
Standalone VAB Devices
Integrated VAB Devices
Needle-based Systems
Manual Systems
Powered Systems
Hospitals
Diagnostic Imaging Centers
Specialty Clinics
Stereotactic VAB
Ultrasound-guided VAB
MRI-guided VAB
Breast Cancer Diagnosis
Benign Lesion Evaluation
Research and Clinical Trials
Europe (Europe, Europe and Mexico)
Europe (Germany, UK, France, Italy, REuropesia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, AEuropetralia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Vacuum-assisted Breast Biopsy(VAB)System Market Research Analysis
1. Introduction of the Europe Vacuum-assisted Breast Biopsy(VAB)System Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Europe Vacuum-assisted Breast Biopsy(VAB)System Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Europe Vacuum-assisted Breast Biopsy(VAB)System Market, By Type
6. Europe Vacuum-assisted Breast Biopsy(VAB)System Market, By Application
7. Europe Vacuum-assisted Breast Biopsy(VAB)System Market, By Geography
Europe
Europe
Asia Pacific
Rest of the World
8. Europe Vacuum-assisted Breast Biopsy(VAB)System Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Europe: Verified Market Reports
Verified Market Reports is a leading Europe Research and Consulting firm servicing over 5000+ Europe clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance Europeing indEuropetrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact Europe:
Mr. Edwyne Fernandes
Europe: +1 (650)-781-4080
Europe Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/